Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia

American Journal of Pathology

Volumn 152, Issue 1, 1998, Pages 209-217

  Chilosi, Marco ^a   Doglioni, Claudio ^b   Yan, Zhanqing ^c   Lestani, Maurizio ^a   Menestrina, Fabio ^a   Sorio, Claudio ^a   Benedetti, Alice ^a   Vinante, Fabrizio ^a   Pizzolo, Giovanni ^a   Inghirami, Giorgio ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b Anat Patologica Osp Civile Feltre   (Italy)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; GROWTH FACTOR; PROTEIN P15; PROTEIN P16; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LYMPHOBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; THYMOCYTE; TUMOR SUPPRESSOR GENE;

BLOTTING, SOUTHERN; BLOTTING, WESTERN; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASES; FETUS; FLOW CYTOMETRY; HUMANS; INFANT; LEUKEMIA; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, LYMPHOBLASTIC; LYMPHOMA, T-CELL; PROTEIN-SERINE-THREONINE KINASES; REFERENCE VALUES; THYMOMA; THYMUS GLAND; THYMUS NEOPLASMS;

EID: 0031963715     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Sherr CJ: G1 phase progression: cycling on cue. Cell 1994, 79:551-555
2. Strauss M, Lukas J, Bartek J: Unrestricted cell cycling and cancer. Nature Med 1995, 1:1245-1246
3. Hirama T, Koeffler HP: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995, 86:841-854
4. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRB function. Genes Dev 1994, 8:2939-2952
5. Karp JE, Broder S: Molecular foundations of cancer: new targets for intervention. Nature Med 1995, 1:309-320
6. Cordon-Cardo C, Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 1995, 147:545-560
7. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato J-Y: D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 1994, 14:2066-2076
8. Meyerson M, Harlow E: Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994, 14:2077-2086
9. Bates S, Bonetta L, MacAllan D, Parry D, Holder A, Dickson C, Peters G: CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene 1994, 9:71-79
10. Kwon TK, Buchholz MA, Gabrielson EW, Nordin AA: A novel cytoplasmic substrate for cdk4 and cdk6 in normal and malignant epithelial derived cells. Oncogene 1995, 11:2077-2083
11. Szepesi A, Gelfand EW, Lucas JJ: Association of proliferating cell nuclear antigen with cyclin-dependent kinases and cyclins in normal and transformed human T lymphocytes. Blood 1994, 84:3413-3421
12. Modiano JF, Domenico J, Szepesi A, Lucas JJ, Gelfand EW: Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. J Biol Chem 1994, 52:32972-32978
13. Lucas JJ, Szepesi A, Modiano JF, Domenico J, Gelfand EW: Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (CDK6), a major cyclin D-associated CDK4 homologue in normal human T lymphocytes. J Immunol 1995, 154:6275-6284
14. Tam SW, Theodoras AM, Shay JW, Draetta GF, Pagano M: Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene 1994, 9:2663-2674
15. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366:704-707
16. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994, 371:257-261
17. Hall M, Bates S, Peters G: Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 1995, 11:1581-1588
18. INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias. Blood 1995, 84:4038-4044
19. Ohnishi H, Kawamura M, Ida K, Sheng XM, Hanada R, Nobori T, Yamamori S, Hayashi Y: Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia. Blood 1995, 86:1269-1275
20. Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP: Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood 1995, 85:2699-2704
21. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995, 85:2321-2330
22. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauters F, Wattel E, Fenaux P: p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 1995, 85:657-663
23. Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen JWG, Reiter A, Ludwig W-D, Zimmermann M, Schwaller J, Lee E, Miyoshi I, Koeffler HP: Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 1995, 86:755-760
24. Cayuela J-M, Madani A, Sanhes L, Stern M-H, Sigaux F: Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood 1996, 87: 2180-2186
25. Chilosi M, Pizzolo G: Review of terminal deoxynucleotidyl transferase: biological aspects, methods of detection, and selected diagnostic applications. Appl Immunohistochem 1995, 3:209-221
26. Marino M, Muller-Hermelink HK: Thymoma and thymic carcinoma: relation of thymoma cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat 1985, 407:119-149
27. Chilosi M, lannucci AM, Pizzolo G, Menestrina F, Fiore-Donati L, Janossy G: Immunohistochemical analysis of thymoma: evidence for medullary origin of epithelial cells. Am J Surg Pathol 1984, 8:309-318
28. Chilosi M, Iannucci A, Fiore-Donati L, Tridente G, Pampanin M, Pizzolo G, Ritter M, Bofill M, Janossy G: Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown. J Neuroimmunol 1986, 11:191-204
29. Chilosi M, Iannucci A, Menestrina F, Lestani M, Scarpa A, Fiore-Donati L, Tridente G, Di Pasquale B, Pizzolo G, Palestro G, Janossy G: Immunohistochemical evidence of active thymocyte proliferation in thymoma: its possible role in the pathogenesis of autoimmune disease. Am J Pathol 1987, 128:464-470
30. Chilosi M, Doglioni C, Menestrina F, Montagna L, Rigo A, Lestani M, Barbareschi M, Scarpa A, Mariuzzi GM, Pizzolo G: Abnormal expression of the p53-binding protein mdm2 in Hodgkin's disease. Blood 1994, 84:4295-4300
31. Inghirami G, Foitl DR, Sabichi A, Zhu BY, Knowles DM: Autoantibody-associated cross-reactive idiotype-bearing human B lymphocytes: distribution and characterization, including Ig VH gene and CD5 antigen expression. Blood 1991, 78:1503-1515
32. Gershoni JM, Palade GE: Protein blotting: principles and applications. Anal Biochem 1983, 131:1-15
33. Pelicci PG, Knowles DM, Magrath I, Dalla-Favera R: Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 1986, 83:2984-2988
34. Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM: Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 1985, 95:315:340-343
35. Wolowiec D, Mekki Y, Ffrench P. Manel AM, Bertrand Y, Rimokh R, Philippe N, Bryon PA, Ffrench M: Differential expression of cell proliferation regulatory proteins in B-and T-lineage acute lymphoblastic leukaemias. Br J Haematol 1996, 518-523
36. Janossy G, Bofill M, Trejdosiewicz LK, Willcox HNA, Chilosi M: Cellular differentiation of lymphoid subpopulations and their microenvironments in the human thymus. The Human Thymus: Histopathology and Pathology. Edited by Muller-Hermelink HK. Berlin, Springer-Verlag, 1986, pp 89-125
37. Kiyokawa H, Richon VM, Rifkind RA, Marks PA: Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol 1994, 14:7195-7203
38. Schmidt EE, Ichimura K, Reifenberger G, Collins VP: CDKN2 (p16/ MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994, 54:6321-6324
39. Sonoda Y, Yoshimoto T, Sekiya T: Homozygous deletion of the MTS1/ p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Oncogene 1995, 11:2145-2149
40. Rhee K, Reisman D, Bresnahn W, Thompson EA: Glucocorticoid regulation of G1 cyclin-dependent kinase genes in lymphoid cells. Cell Growth Differ 1995, 6:691-698
41. Abe J, Zhou W, Takuwa N, Taguchi J, Kurokawa K, Kumada M, Takuwa Y: A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. Cancer Res 1994, 54:3407-3412
42. Marks PA, Richon VM, Kiyokawa H, Rifkind RA: Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process. Proc Natl Acad Sci USA 1994, 91:10251-10254
43. Vesely J, Havlicek L, Strand M, Blow JJ, Donella-Deana A, Pinna L, Letham DS, Kato J-Y, Detivaud L, Leclerc S, Meijer L: Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem 1994, 224:771-786
44. Akagi T, Ono H, Shimotohno K: Tyrosine kinase inhibitor herbimycin A reduces the stability of cyclin-dependent kinase Cdk6 protein in T-cells. Oncogene 1996, 13:399-405
45. Friedman HD, Hutchison RE, Kohman LJ, Powers CN: Thymoma mimicking lymphoblastic lymphoma: a pitfall in fine-needle aspiration biopsy interpretation. Diagn Cytopathol 1996, 14:165-171
46. Scarpa A, Chilosi M, Capelli P, Bonetti F, Menestrina F, Zamboni G, Pizzolo G, Palestro G, Fiore-Donati L, Tridente G: Expression and gene rearrangement of the T-cell receptor in human thymomas. Virchows Arch B Cell Pathol 1990, 58:235-239